Barclays PLC Cellebrite Di Ltd. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Barclays PLC holds 2,723 shares of CLBT stock, worth $50,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,723
Previous 140,037
98.06%
Holding current value
$50,239
Previous $2.24 Million
97.77%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CLBT
# of Institutions
215Shares Held
117MCall Options Held
445KPut Options Held
257K-
True Wind Capital Management, L.P.13.9MShares$256 Million94.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10MShares$185 Million0.11% of portfolio
-
Voss Capital, LLC Houston, TX6.78MShares$125 Million7.12% of portfolio
-
Invesco Ltd. Atlanta, GA5.56MShares$103 Million0.02% of portfolio
-
Pertento Partners LLP London, X04.65MShares$85.8 Million13.09% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.5B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...